Lung cancer remains one of the leading causes of cancer-related deaths worldwide. With advancements in precision medicine, Afatinib tablets have become an effective targeted treatment option for patients diagnosed with EGFR mutation-positive Non-Small Cell Lung Cancer (NSCLC).
Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical company supplying high-quality Afatinib 20mg, 30mg, and 40mg tablets to healthcare providers, hospitals, distributors, and oncology centers across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Afatinib?
Afatinib is an oral tyrosine kinase inhibitor (TKI) that blocks the activity of epidermal growth factor receptor (EGFR) proteins responsible for cancer cell growth.
It is primarily prescribed for:
EGFR mutation-positive metastatic Non-Small Cell Lung Cancer (NSCLC)
Advanced squamous cell carcinoma of the lungs
Patients requiring targeted cancer therapy
Afatinib works by slowing or stopping the growth and spread of cancer cells.
Available Strengths
Cordium Pharmaceuticals Pvt Ltd offers:
Afatinib 20mg Tablets
Suitable for dose adjustments and patients sensitive to treatment.
Afatinib 30mg Tablets
Commonly prescribed maintenance dose for long-term treatment.
Afatinib 40mg Tablets
Standard starting dose for many EGFR-positive NSCLC patients.
Benefits of Afatinib Tablets
Precision Targeted Therapy
Targets specific EGFR mutations instead of affecting all cells.
Improved Progression-Free Survival
Helps delay cancer progression in eligible patients.
Oral Administration
Convenient tablet form without frequent hospital visits.
Better Quality of Life
Reduces dependency on conventional chemotherapy in suitable patients.
Globally Recognized Treatment
Recommended in international oncology treatment guidelines.
How Does Afatinib Work?
Afatinib irreversibly blocks multiple members of the ErbB receptor family including:
EGFR (ErbB1)
HER2 (ErbB2)
ErbB4
This inhibits signaling pathways that promote:
Cancer cell growth
Tumor multiplication
Cancer spread (metastasis)
Dosage Information
Important: Afatinib should only be used under the supervision of an oncologist.
Typical dosage:
Initial dose: 40mg once daily
Dose reduction: 30mg or 20mg based on tolerance and side effects
Take on an empty stomach
Patients must never self-adjust their dosage.
Common Side Effects
Some patients may experience:
Diarrhea
Skin rash
Dry skin
Mouth sores
Nail infections
Reduced appetite
Fatigue
Seek immediate medical advice if severe side effects occur.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
WHO-GMP Quality Standards
Manufactured under stringent international guidelines.
Global Export Expertise
Supplying oncology medicines worldwide.
Competitive Pricing
Affordable cancer treatment solutions.
Reliable Supply Chain
Consistent availability for hospitals and distributors.
Regulatory Documentation Support
Comprehensive export documentation assistance.
Countries We Serve
Cordium Pharmaceuticals Pvt Ltd actively exports Afatinib tablets to:
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Asia
🇵🇭 Philippines
🇻🇳 Vietnam
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Middle East
🇦🇪 UAE
🇸🇦 Saudi Arabia
Europe & North America
🇬🇧 UK
🇺🇸 USA
Who Can Partner With Us?
We welcome inquiries from:
Oncology hospitals
Government healthcare agencies
Pharmaceutical importers
Medical distributors
Cancer treatment centers
International wholesalers
Frequently Asked Questions (FAQs)
Is Afatinib chemotherapy?
No. Afatinib is a targeted therapy medicine, not traditional chemotherapy.
Is Afatinib used for lung cancer?
Yes. It is primarily used for EGFR mutation-positive Non-Small Cell Lung Cancer (NSCLC).
Can Afatinib cure lung cancer?
Afatinib does not cure cancer but helps control disease progression and improve patient outcomes.
Is a prescription required?
Yes. Afatinib is a prescription-only oncology medication.
Looking for a trusted global supplier of Afatinib 20mg, 30mg, and 40mg Tablets?
Cordium Pharmaceuticals Pvt Ltd delivers high-quality oncology medicines worldwide with reliable supply chains, competitive pricing, and international export support.
Contact us today for bulk orders, distributor partnerships, and global export inquiries.
Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical company supplying high-quality Afatinib 20mg, 30mg, and 40mg tablets to healthcare providers, hospitals, distributors, and oncology centers across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Afatinib?
Afatinib is an oral tyrosine kinase inhibitor (TKI) that blocks the activity of epidermal growth factor receptor (EGFR) proteins responsible for cancer cell growth.
It is primarily prescribed for:
EGFR mutation-positive metastatic Non-Small Cell Lung Cancer (NSCLC)
Advanced squamous cell carcinoma of the lungs
Patients requiring targeted cancer therapy
Afatinib works by slowing or stopping the growth and spread of cancer cells.
Available Strengths
Cordium Pharmaceuticals Pvt Ltd offers:
Afatinib 20mg Tablets
Suitable for dose adjustments and patients sensitive to treatment.
Afatinib 30mg Tablets
Commonly prescribed maintenance dose for long-term treatment.
Afatinib 40mg Tablets
Standard starting dose for many EGFR-positive NSCLC patients.
Benefits of Afatinib Tablets
Precision Targeted Therapy
Targets specific EGFR mutations instead of affecting all cells.
Improved Progression-Free Survival
Helps delay cancer progression in eligible patients.
Oral Administration
Convenient tablet form without frequent hospital visits.
Better Quality of Life
Reduces dependency on conventional chemotherapy in suitable patients.
Globally Recognized Treatment
Recommended in international oncology treatment guidelines.
How Does Afatinib Work?
Afatinib irreversibly blocks multiple members of the ErbB receptor family including:
EGFR (ErbB1)
HER2 (ErbB2)
ErbB4
This inhibits signaling pathways that promote:
Cancer cell growth
Tumor multiplication
Cancer spread (metastasis)
Dosage Information
Important: Afatinib should only be used under the supervision of an oncologist.
Typical dosage:
Initial dose: 40mg once daily
Dose reduction: 30mg or 20mg based on tolerance and side effects
Take on an empty stomach
Patients must never self-adjust their dosage.
Common Side Effects
Some patients may experience:
Diarrhea
Skin rash
Dry skin
Mouth sores
Nail infections
Reduced appetite
Fatigue
Seek immediate medical advice if severe side effects occur.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
WHO-GMP Quality Standards
Manufactured under stringent international guidelines.
Global Export Expertise
Supplying oncology medicines worldwide.
Competitive Pricing
Affordable cancer treatment solutions.
Reliable Supply Chain
Consistent availability for hospitals and distributors.
Regulatory Documentation Support
Comprehensive export documentation assistance.
Countries We Serve
Cordium Pharmaceuticals Pvt Ltd actively exports Afatinib tablets to:
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Asia
🇵🇭 Philippines
🇻🇳 Vietnam
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Middle East
🇦🇪 UAE
🇸🇦 Saudi Arabia
Europe & North America
🇬🇧 UK
🇺🇸 USA
Who Can Partner With Us?
We welcome inquiries from:
Oncology hospitals
Government healthcare agencies
Pharmaceutical importers
Medical distributors
Cancer treatment centers
International wholesalers
Frequently Asked Questions (FAQs)
Is Afatinib chemotherapy?
No. Afatinib is a targeted therapy medicine, not traditional chemotherapy.
Is Afatinib used for lung cancer?
Yes. It is primarily used for EGFR mutation-positive Non-Small Cell Lung Cancer (NSCLC).
Can Afatinib cure lung cancer?
Afatinib does not cure cancer but helps control disease progression and improve patient outcomes.
Is a prescription required?
Yes. Afatinib is a prescription-only oncology medication.
Looking for a trusted global supplier of Afatinib 20mg, 30mg, and 40mg Tablets?
Cordium Pharmaceuticals Pvt Ltd delivers high-quality oncology medicines worldwide with reliable supply chains, competitive pricing, and international export support.
Contact us today for bulk orders, distributor partnerships, and global export inquiries.
Keywords
